Analysts believe Aurobindo has multiple growth drivers in place with investments in vaccines, injectables, biosimilars and PLI, which are expected to be reflected from FY24
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Analysts believe Aurobindo has multiple growth drivers in place with investments in vaccines, injectables, biosimilars and PLI, which are expected to be reflected from FY24
| Subscribe To Our Free Newsletter |
